Miracle Automation Engineering (002009.SZ)'s application for issuing shares to specific targets has received approval for registration from the China Securities Regulatory Commission.
Miracle Automation Engineering (002009.SZ) announced that on September 24, 2026, the company received the "Approval for the Registration of Issuing Shares to Specific Targets by Miracle Automation Engineering Co., Ltd." issued by the China Securities Regulatory Commission (CSRC), approving the company's registration application for issuing shares to specific targets.
Miracle Automation Engineering (002009.SZ) announced that on September 24, 2026, the company received the "Approval for the Registration of Issuing Shares to Specific Targets by Miracle Automation Engineering Co., Ltd." issued by the China Securities Regulatory Commission (CSRC), approving the company's registration application for issuing shares to specific targets.
Related Articles
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang included in the breakthrough therapy designation list
FANGZHOU JIANKE (06086) Caina Technology Incentive Plan
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang included in the breakthrough therapy designation list
FANGZHOU JIANKE (06086) Caina Technology Incentive Plan
